Trending...
- City of Tacoma Secures Over $4 Million in Transportation Improvement Board Grants
- TBM Council Appoints Four Distinguished Leaders to Board of Directors
- Spokane: Council Members Official Swearing In Ceremony
TAMPA, Fla. - Washingtoner -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
More on Washingtoner
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777
More on Washingtoner
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
- 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
- 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
- Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
- Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
- Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
More on Washingtoner
- $6.4 Million Purchase of Construction Vehicles Plus New Dealership Agreement with Cycle & Carriage for Heavy Equipment Provider to Singapore Region
- CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
- Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
- New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
- ICHRRF welcomes Sanjaya Sarpong-Kumankumah as Director of Outreach for African Traditional Religions
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777
More on Washingtoner
- Erik Kalasunas Joins ICHRRF As Director of Communications
- Spokane: Council Members Official Swearing In Ceremony
- International Law Group Expands Emergency Immigration Consultations for Somali Minnesotans Amid ICE Actions
- Spokane: Male In Custody After Domestic Violence Court Order Service Results In Emergent Entry Into A Residence; Multiple Firearms Recovered
- Sergio C. Flores Appointed Tacoma Municipal Court Judge
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
Source: Juventix Regenerative Medical, LLC
0 Comments
Latest on Washingtoner
- $1 Million Share Repurchase Signals Confidence as Off The Hook YS Scales a Tech-Driven Platform in the $57 Billion U.S. Marine Market
- Trends Journal's Top Trends of 2026
- CollabWait to Launch Innovative Waitlist Management Platform for Behavioral Health Services
- Urban Bush Women Celebrates Bessie Award Nominations & Winter 2026 Touring
- Imagen Golf Launches "Precision Lessons" with Trackman iO in Newtown, PA
- New Report Reveals Surprising Trends in Illinois Airport Accidents
- PebblePad Acquires myday to Deliver Unified Digital Campus Experiences for Student Success
- Adam Clermont Releases New Book – Profit Before People: When Corporations Knew It Was Dangerous and Sold It Anyway
- 30 Community Art Projects Funded by the Tacoma Arts Commission
- Dirty Heads, 311, Tropidelic, and The Movement to Headline Everwild Music Festival in 2026 with its largest lineup to date!
- The Stork Foundation Announces 2025 Year-End Impact and Grant Awards Amid Rising National Demand
- Stout Industrial Technology Appoints Paul Bonnett as Chief Executive Officer
- Revenue Optics Appoints Ljupco Icevski as Executive Advisor in Strategic Move to Accelerate Commercial Development
- Waarom brand mentions in ChatGPT steeds belangrijker worden
- Tacoma: City Council Approves 0.1% Criminal Justice Sales & Use Tax to Enhance Community Safety and Support Vital Services
- Tacoma: District 5 Council Member Joe Bushnell to Serve as Deputy Mayor in 2026
- City of Tacoma Secures Over $4 Million in Transportation Improvement Board Grants
- Sandesh Sadalge Sworn in as District 4 Tacoma City Council Member for First Full Term
- Tacoma: District 2 Council Member Sarah Rumbaugh Begins Second Term
- Latasha Palmer Begins Serving as Tacoma City Council Member, At-Large Position 6



